glp 1 agonist route of administration Dosage GLP-1 analogues GLP-1 Agonists Transform Diabetes &
Description
Sarkar, S
Am J Physiol Endocrinol Metab 2001;280:E270-E279
(2011) 6:e22623
For 2,567 semaglutide users who stopped treatment, 33% regained weight, 32% maintained weight loss, and 35% continued losing weight
Weight loss is undeniably a major contributor, as it improves blood pressure, lipids, glycemic control, and systemic inflammation
